60 Degrees Pharmaceuticals I
13F holders, Q2 2025 (June 30)5holders −1
0new positions
1sold out
$2.37avg. 13F price*
At the end of Q2 2025, 5 institutions reported holding 60 Degrees Pharmaceuticals I in their 13F filings, down 1 from Q1 2025. 0 opened new positions and 1 sold out. The largest holders were Geode Capital Management, LLC ($30K), Tower Research Capital LLC (TRC) ($6K) and Osaic Holdings, Inc. ($237).
- Company
- 60 Degrees Pharmaceuticals I
- CUSIP
- 83006G401
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $506 |
All 13F filers, Q1 2025 → Q2 2025: 1,641 shares bought and 16,449 shares sold, net −14,808 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Geode Capital Management, LLC | 0.00% | Add +5.0% | 12,516 | $30K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +67.6% | 2,598 | $6K |
| Osaic Holdings, Inc. | 0.00% | No change | 100 | $237 |
| UBS Group AG | 0.00% | Reduce -99.9% | 14 | $33 |
| Bank of America Corp. | 0.00% | Add +8.3% | 13 | $30 |
"% of holder's portfolio" is 60 DEGREES PHARMACEUTICALS I's weight in each manager's 13F, not the share of 60 Degrees Pharmaceuticals I the manager owns.